- Home
- IRON vs KN Comparison
IRON vs KN Comparison
Compare IRON & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- KN
- Stock Information
- Founded
- IRON 2017
- KN 1946
- Country
- IRON United States
- KN United States
- Employees
- IRON N/A
- KN N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- KN Consumer Electronics/Appliances
- Sector
- IRON Health Care
- KN Consumer Staples
- Exchange
- IRON Nasdaq
- KN Nasdaq
- Market Cap
- IRON 2.0B
- KN 1.8B
- IPO Year
- IRON N/A
- KN N/A
- Fundamental
- Price
- IRON $59.82
- KN $22.14
- Analyst Decision
- IRON Strong Buy
- KN Buy
- Analyst Count
- IRON 10
- KN 3
- Target Price
- IRON $97.80
- KN $21.00
- AVG Volume (30 Days)
- IRON 301.7K
- KN 513.6K
- Earning Date
- IRON 11-11-2025
- KN 10-23-2025
- Dividend Yield
- IRON N/A
- KN N/A
- EPS Growth
- IRON N/A
- KN N/A
- EPS
- IRON N/A
- KN 0.28
- Revenue
- IRON N/A
- KN $563,100,000.00
- Revenue This Year
- IRON N/A
- KN $8.20
- Revenue Next Year
- IRON N/A
- KN $5.13
- P/E Ratio
- IRON N/A
- KN $79.18
- Revenue Growth
- IRON N/A
- KN 9.17
- 52 Week Low
- IRON $30.82
- KN $12.19
- 52 Week High
- IRON $68.73
- KN $22.31
- Technical
- Relative Strength Index (RSI)
- IRON 50.30
- KN 65.46
- Support Level
- IRON $58.59
- KN $21.08
- Resistance Level
- IRON $61.27
- KN $21.98
- Average True Range (ATR)
- IRON 2.13
- KN 0.43
- MACD
- IRON -0.15
- KN 0.01
- Stochastic Oscillator
- IRON 18.47
- KN 89.51
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.